Moufarrej A, Biermann S, Springer R, Hoff NP, et al. Targeted BRAF /MEK inhibition as a salvage therapy for patients with metastatic melanoma harboring a BRAF L597R mutation: two case reports and review of the literature. Melanoma Res 2026 Aug 31. doi: 10.1097/CMR.0000000000001135.
PMID: 42678759